M A Arneson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M A Arneson

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

JAMA|July 11, 1980

A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.

The Journal of Trauma|June 24, 2000

Rib fractures in the elderlyE M Bulger, M A Arneson, C N Mock, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980

Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agentsB J Gormus, M L Basara, M A Arneson, et al.

Annals of Surgery|February 1, 1979

Pancreatitis as a complication of anticholinesterase insecticide intoxicationT D Dressel, R L Goodale, M A Arneson, et al.

Cellular Immunology|September 15, 1980

The bacteria(B)--antibody(A)--complement(C) (BAC) rosette method for detecting C3 receptors (R): binding specificity and capping of human peripheral blood lymphocyte C3rB J Gormus, M L Basara, J Cossman, et al.

JAMA|November 19, 1982

Maternal Ehlers-Danlos syndrome type X. Successful management of pregnancy and parturitionD E Hammerschmidt, M A Arneson, S L Larson, et al.

Leukemia & Lymphoma|January 1, 1994

Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.

Infection Control and Hospital Epidemiology|March 1, 1993

Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplantsP C Iwen, E C Reed, J O Armitage, et al.

Antisense Research and Development|January 1, 1993

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.

The American Review of Respiratory Disease|August 1, 1992

Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin diseaseJ H Sisson, A B Thompson, J R Anderson, et al.

Pageof 2

Search research articles

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

JAMA|July 11, 1980

A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.

The Journal of Trauma|June 24, 2000

Rib fractures in the elderlyE M Bulger, M A Arneson, C N Mock, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980

Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agentsB J Gormus, M L Basara, M A Arneson, et al.

Annals of Surgery|February 1, 1979

Pancreatitis as a complication of anticholinesterase insecticide intoxicationT D Dressel, R L Goodale, M A Arneson, et al.

Cellular Immunology|September 15, 1980

The bacteria(B)--antibody(A)--complement(C) (BAC) rosette method for detecting C3 receptors (R): binding specificity and capping of human peripheral blood lymphocyte C3rB J Gormus, M L Basara, J Cossman, et al.

JAMA|November 19, 1982

Maternal Ehlers-Danlos syndrome type X. Successful management of pregnancy and parturitionD E Hammerschmidt, M A Arneson, S L Larson, et al.

Leukemia & Lymphoma|January 1, 1994

Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequencesE Bayever, K M Haines, P L Iversen, et al.

Infection Control and Hospital Epidemiology|March 1, 1993

Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplantsP C Iwen, E C Reed, J O Armitage, et al.

Antisense Research and Development|January 1, 1993

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.

The American Review of Respiratory Disease|August 1, 1992

Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin diseaseJ H Sisson, A B Thompson, J R Anderson, et al.

Pageof 2